FI906246A - Förfarande för framställning av nya terapeutiskt användbara 1-(4-fluorfenyl)-2-(1-piperidyl)etanonderivat - Google Patents
Förfarande för framställning av nya terapeutiskt användbara 1-(4-fluorfenyl)-2-(1-piperidyl)etanonderivat Download PDFInfo
- Publication number
- FI906246A FI906246A FI906246A FI906246A FI906246A FI 906246 A FI906246 A FI 906246A FI 906246 A FI906246 A FI 906246A FI 906246 A FI906246 A FI 906246A FI 906246 A FI906246 A FI 906246A
- Authority
- FI
- Finland
- Prior art keywords
- piperidyl
- fluorophenyl
- preparation
- therapeutically useful
- new therapeutically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45449789A | 1989-12-21 | 1989-12-21 | |
US45449789 | 1989-12-21 | ||
US60465190A | 1990-11-01 | 1990-11-01 | |
US60465190 | 1990-11-01 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI906246A0 FI906246A0 (sv) | 1990-12-18 |
FI906246A true FI906246A (sv) | 1991-06-22 |
FI96946B FI96946B (sv) | 1996-06-14 |
FI96946C FI96946C (sv) | 1996-09-25 |
Family
ID=27037488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI906246A FI96946C (sv) | 1989-12-21 | 1990-12-18 | Förfarande för framställning av nya terapeutiskt användbara 1-(4-fluorfenyl)-2-(1-piperidyl)etanonderivat |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0437790B1 (sv) |
JP (1) | JP2934323B2 (sv) |
KR (1) | KR0184641B1 (sv) |
CN (1) | CN1025853C (sv) |
AR (1) | AR247200A1 (sv) |
AT (1) | ATE133163T1 (sv) |
AU (1) | AU635098B2 (sv) |
CA (1) | CA2032797C (sv) |
DE (1) | DE69024933T2 (sv) |
DK (1) | DK0437790T3 (sv) |
ES (1) | ES2084642T3 (sv) |
FI (1) | FI96946C (sv) |
GR (1) | GR3018895T3 (sv) |
HU (1) | HU210590B (sv) |
IE (1) | IE71039B1 (sv) |
IL (1) | IL96731A (sv) |
NO (1) | NO176565C (sv) |
NZ (1) | NZ236501A (sv) |
PT (1) | PT96291B (sv) |
TW (1) | TW199145B (sv) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292752A (en) * | 1989-12-21 | 1994-03-08 | Merrell Dow Pharmaceuticals Inc. | Antithrombotic compounds |
US5478846A (en) * | 1990-06-07 | 1995-12-26 | Merrell Dow Pharmaceuticals Inc. | 1-piperidinyl alkanoylanyl sulfonamides for treatment of cardiac arrhythmia |
CA2084082C (en) * | 1990-06-07 | 2002-03-19 | Albert A. Carr | 1-pyperidinyl alkanoylarysulfonamide derivatives |
EP0661266A1 (en) * | 1993-12-27 | 1995-07-05 | Toa Eiyo Ltd. | Substituted cyclic amine compounds as 5HT2 antagonists |
JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4355037A (en) * | 1981-11-12 | 1982-10-19 | Hoechst-Roussel Pharmaceuticals | 3-(4-Piperidyl)-1,2-benzisoxales |
FR2581993B1 (fr) * | 1985-05-14 | 1988-03-18 | Synthelabo | Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique |
PH23283A (en) * | 1986-02-26 | 1989-06-30 | Eisai Co Ltd | Piperidine derivative, pharmaceutical composition containing the same and method of use thereof |
AU609385B2 (en) * | 1987-01-12 | 1991-05-02 | Dominic A. Ricchio | Method and apparatus for improved water therapy |
US5093341A (en) * | 1987-12-17 | 1992-03-03 | Merrell Dow Pharmaceuticals Inc. | N-aralkyl piperidine derivatives useful as antithrombolytic agents |
US5064838A (en) * | 1988-01-21 | 1991-11-12 | Merrell Dow Pharmaceuticals | 1,4-disubstituted-piperidinyl compounds as pain relievers |
JP2969359B2 (ja) * | 1989-01-13 | 1999-11-02 | 武田薬品工業株式会社 | 環状アミン化合物 |
-
1990
- 1990-12-17 NZ NZ236501A patent/NZ236501A/en unknown
- 1990-12-18 TW TW079110633A patent/TW199145B/zh active
- 1990-12-18 AU AU68181/90A patent/AU635098B2/en not_active Ceased
- 1990-12-18 FI FI906246A patent/FI96946C/sv not_active IP Right Cessation
- 1990-12-19 JP JP2411705A patent/JP2934323B2/ja not_active Expired - Fee Related
- 1990-12-19 IL IL9673190A patent/IL96731A/en not_active IP Right Cessation
- 1990-12-20 AR AR90318688A patent/AR247200A1/es active
- 1990-12-20 ES ES90124973T patent/ES2084642T3/es not_active Expired - Lifetime
- 1990-12-20 KR KR1019900021184A patent/KR0184641B1/ko not_active IP Right Cessation
- 1990-12-20 DE DE69024933T patent/DE69024933T2/de not_active Expired - Fee Related
- 1990-12-20 DK DK90124973.0T patent/DK0437790T3/da active
- 1990-12-20 CA CA002032797A patent/CA2032797C/en not_active Expired - Fee Related
- 1990-12-20 PT PT96291A patent/PT96291B/pt not_active IP Right Cessation
- 1990-12-20 AT AT90124973T patent/ATE133163T1/de not_active IP Right Cessation
- 1990-12-20 CN CN90110137.0A patent/CN1025853C/zh not_active Expired - Fee Related
- 1990-12-20 EP EP90124973A patent/EP0437790B1/en not_active Expired - Lifetime
- 1990-12-20 HU HU908370A patent/HU210590B/hu not_active IP Right Cessation
- 1990-12-20 NO NO905511A patent/NO176565C/no not_active IP Right Cessation
- 1990-12-20 IE IE463290A patent/IE71039B1/en not_active IP Right Cessation
-
1996
- 1996-02-01 GR GR960400292T patent/GR3018895T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO179639C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser | |
FI890282A0 (sv) | Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat | |
FI905941A (sv) | Förfarande för framställning av terapeutiskt användbara heterocykliska 2-acylaminotiazolderivat | |
FI94250B (sv) | Förfarande för framställning av nya, terapeutiskt användbara etrar | |
NO900795D0 (no) | Fremgangsmaate for fremstilling av nye 2-(1-piperazinyl)-4-fenylcykloalkan-pyrimidinderivater. | |
NO900032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser. | |
NO891191D0 (no) | Fremgangsmaate for fremstilling av nye, terapeutisk virksomme catecholderivater. | |
PT87717A (pt) | Process for preparing 2,4-thiazolidinedione derivatives | |
NO177096C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner | |
NO173784C (no) | Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater | |
NO175976C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater | |
FI91964C (sv) | Förfarande för framställning av nya, farmaceutiskt aktiva 1-(hydroxistyryl)-5H-2,3-bensodiazepinderivat | |
NO903112D0 (no) | Fremgangsmaate for fremstilling av 3-substituerte vinylcefalosporinderivater. | |
NO902084L (no) | Fremgangsmaate for fremstilling av substituerte pyrrolforbindelser. | |
NO901813L (no) | Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater. | |
FI903431A0 (sv) | Förfarande för framställning av nya, terapeutiskt användbara kromanderivat | |
FI906246A (sv) | Förfarande för framställning av nya terapeutiskt användbara 1-(4-fluorfenyl)-2-(1-piperidyl)etanonderivat | |
NO901071D0 (no) | Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater. | |
FI906084A (sv) | Förfarande för framställning av nya terapeutiskt användbara 5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indolderivat | |
DE69013131D1 (de) | 2-(2-Cyclopropylpyrrolidin-4-ylthio)carbapenemderivate. | |
PT86623A (pt) | Process for the preparation of derivatives of 3-aryl-5-alkylthio-4h-1,2,4-triazoles | |
FI900129A (sv) | Förfarande för framställning av 2-(N-fenylacetylaminopiperidin)-2,6-dion | |
NO903397D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd. | |
NO174393C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-metyl-19-nor-pregna-4,6-diener som er 17 eventuelt 21-alkylert | |
NO900381D0 (no) | Fremgangsmaate for fremstilling av nafthalenderivater. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MM | Patent lapsed |
Owner name: MERRELL DOW PHARMACEUTICALS INC. |